Cevimeline Hydrochloride Hemihydrate is a muscarinic receptor agonist mainly used to treat dry mouth (xerostomia) in patients with Sjögren’s syndrome. It selectively stimulates M3 receptors on exocrine glands, enhancing saliva and tear production. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Evoxac (TN), Saligren (TN) and DTXSID9022788. Its PubChem CID is 83927.
Cevimeline hydrochloride hemihydrate
| CAS No | 153504-70-2 |
|---|---|
| Molecular Formula | C20H38Cl2N2O3S2 |
| Molecular Weight | 489.6 g/mol |
| Synonyms | bis((2R,5R)-2-methylspiro[1,3-oxathiolane-5,3′-1-azabicyclo[2.2.2]octane]);hydrate;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cevimeline Hydrochloride Hemihydrate is a muscarinic receptor agonist mainly used to treat dry mouth (xerostomia) in patients with Sjögren’s syndrome. It selectively stimulates M3 receptors on exocrine glands, enhancing saliva and tear production.
The listed CAS number is 153504-70-2.
The listed molecular formula is C20H38Cl2N2O3S2.
The listed molecular weight is 489.6 g/mol.
bis((2R,5R)-2-methylspiro[1,3-oxathiolane-5,3′-1-azabicyclo[2.2.2]octane]);hydrate;dihydrochloride.
The source lists Evoxac (TN), Saligren (TN) and DTXSID9022788.